Global Artificial Blood Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025
Global Artificial Blood Market is expected to reach $10.7 billion by 2025. The expected growth rate is 20.3% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Artificial Blood Market. The market sizing is provided from 2017 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:
ALLIANCE PHARMACEUTICAL CORP
BAXTER HEALTHCARE CORP.
NORTHFIELD LABORATORIES INC.
NUVOX PHARMA LLC.
PROLONG PHARMACEUTICALS, LLC
TENAX THERAPEUTICS INC.
THERAPURE BIOPHARMA INC.
Scope of the Market
Artificial Blood Developed From Human Blood
Artificial Blood Developed From Animal Blood
Artificial Blood Developed Using Recombinant Technology
Hemoglobin Based Oxygen CarriersDiabetes
Global Potential Artificial Blood Market
Rest of the World (RoW)